Malte Greune is the founder of CureVac. CureVac has raised $975M in total funding. Latest round: Series F. Based in Tübingen, Germany.
Malte Greune is the Chief Operating Officer (COO) at CureVac, a clinical-stage biopharmaceutical company focused on developing transformative medicines using messenger ribonucleic acid (mRNA). Appointed to this role on July 1, 2021, he is responsible for strengthening the company's Management Board and overseeing its clinical and commercial manufacturing activities. Greune brings extensive experience from the global pharmaceutical industry, including manufacturing vaccines and biologics. Before joining CureVac, he held various management positions at Sanofi-Aventis Deutschland GmbH for nearly ten years, where he was responsible for several manufacturing sites.
Full founder directory · Investor directory · Company funding database · Fundraising library